Trimodulin (Biotest)

N/A

Report date: 2022/09/09 20:00:42

Base Information

Drug NameTrimodulin (Biotest)
Drug Alias NameBT 588IgM concentrate - BiotestBT588BT 086BT086 +[7] 
ClassificationBiologics > Blood componentsBiologics > Protein drugs > ImmunoglobulinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Community Acquired PneumoniaRespiratory Distress Syndrome, Adult +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[24] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBiotest Ag
China Registration ClassN/A

Develop Information

Active CompaniesBiotest Ag
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Community Acquired Pneumonia
Inactive IndicationsRespiratory Distress Syndrome, AdultPneumonia, ViralPneumonia +[5] 

Other Information

ATC CodeN/A
Related LinksN/A